Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (145)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chinnery, P. F.
Right arrow Articles by Turnbull, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinnery, P. F.
Right arrow Articles by Turnbull, D. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 10 1713-1721, Copyright © 1997 by Oxford University Press

ARTICLES

Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes

PF Chinnery, N Howell, RN Lightowlers and DM Turnbull
Department of Neurology, University of Newcastle upon Tyne, UK.

Many patients with inherited mitochondrial encephalopathies have one of two pathogenic mutations of mitochondrial DNA (mtDNA): A3243G or A8344G. Individuals who harbour these mutations carry both mutant and wild-type alleles within each cell (heteroplasmy). Despite clear evidence of a direct relationship between the level of mutation and mitochondrial respiratory chain function in vitro, it has been more difficult to demonstrate a clear correlation between clinical phenotype and the level of mutant mtDNA in vivo. To address this issue, we identified 245 individuals who carry either the A3243G or A8344G mutations, and studied the relationship between the incidence of specific clinical features and the level of mutant mtDNA in blood (for A3243G, n = 73; for A8344G, n = 25) and/or skeletal muscle (for A3234G, n = 111; for A8344G, n = 55). Within this study group, the frequency of key clinical features was significantly different for individuals harbouring the A3243G and A8344G mutations. For both mutations, there was a correlation between the frequency of the more common clinical features and the level of mutant mtDNA in muscle. In contrast, we did not observe a correlation between the frequency of clinical features and the level of mutant mtDNA in blood. Therefore, measurement of the level of the A3243G and A8344G mutations in muscle will allow the identification of individuals who are at risk of developing specific complications, thus improving the prognostic advice that can be given to patients and family members who carry these mutations.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Frederiksen, T. D. Jeppesen, J. Vissing, M. Schwartz, K. O. Kyvik, O. Schmitz, P. L. Poulsen, and P. H. Andersen
High Prevalence of Impaired Glucose Homeostasis and Myopathy in Asymptomatic and Oligosymptomatic 3243A>G Mitochondrial DNA Mutation-Positive Subjects
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2872 - 2879.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
T. D. Jeppesen, M. C. Orngreen, G. van Hall, R. G. Haller, and J. Vissing
Fat Metabolism During Exercise in Patients With Mitochondrial Disease
Arch Neurol, March 1, 2009; 66(3): 365 - 370.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. G. Whittaker, J. K. Blackwood, C. L. Alston, E. L. Blakely, J. L. Elson, R. McFarland, P. F. Chinnery, D. M. Turnbull, and R. W. Taylor
URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION
Neurology, February 10, 2009; 72(6): 568 - 569.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
P. Kaufmann, K. Engelstad, Y. Wei, R. Kulikova, M. Oskoui, V. Battista, D. Y. Koenigsberger, J. M. Pascual, M. Sano, M. Hirano, et al.
Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
Arch Neurol, January 1, 2009; 66(1): 85 - 91.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
F. Sasarman, H. Antonicka, and E. A. Shoubridge
The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2
Hum. Mol. Genet., December 1, 2008; 17(23): 3697 - 3707.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
R G E van Eijsden, L M T Eijssen, P J Lindsey, C M M van den Burg, L E A de Wit, M E Rubio-Gozalbo, C E M de Die, T Ayoubi, W Sluiter, I F M de Coo, et al.
Termination of damaged protein repair defines the occurrence of symptoms in carriers of the m.3243A>G tRNALeu mutation
J. Med. Genet., August 1, 2008; 45(8): 525 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
P P Rath, S Jenkins, M Michaelides, A Smith, M G Sweeney, M B Davis, F W Fitzke, and A C Bird
Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence
Br J Ophthalmol, May 1, 2008; 92(5): 623 - 629.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. Michaelides, S. A. Jenkins, D.-E. Bamiou, M. G. Sweeney, M. B. Davis, L. Luxon, A. C. Bird, and P. P. Rath
Macular Dystrophy Associated With the A3243G Mitochondrial DNA Mutation: Distinct Retinal and Associated Features, Disease Variability, and Characterization of Asymptomatic Family Members
Arch Ophthalmol, March 1, 2008; 126(3): 320 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
L. Jacobs, M. Gerards, P. Chinnery, J. Dumoulin, I. de Coo, J. Geraedts, and H. Smeets
mtDNA point mutations are present at various levels of heteroplasmy in human oocytes
Mol. Hum. Reprod., March 1, 2007; 13(3): 149 - 154*.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
A. Pyle, R. W Taylor, S. E Durham, M. Deschauer, A. M Schaefer, D. C Samuels, and P. F Chinnery
Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation
J. Med. Genet., January 1, 2007; 44(1): 69 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
T. D. Jeppesen, M. Schwartz, A. L. Frederiksen, F. Wibrand, D. B. Olsen, and J. Vissing
Muscle Phenotype and Mutation Load in 51 Persons With the 3243A>G Mitochondrial DNA Mutation
Arch Neurol, December 1, 2006; 63(12): 1701 - 1706.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K.A.M. Majamaa-Voltti, S. Winqvist, A. M. Remes, U. Tolonen, J. Pyhtinen, S. Uimonen, M. Karppa, M. Sorri, K. Peuhkurinen, and K. Majamaa
A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA
Neurology, May 23, 2006; 66(10): 1470 - 1475.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
H. Fan, C. Civalier, J. K. Booker, M. L. Gulley, T. W. Prior, and R. A. Farber
Detection of Common Disease-Causing Mutations in Mitochondrial DNA (Mitochondrial Encephalomyopathy, Lactic Acidosis with Stroke-Like Episodes MTTL1 3243 A>G and Myoclonic Epilepsy Associated with Ragged-Red Fibers MTTK 8344A>G) by Real-Time Polymerase Chain Reaction
J. Mol. Diagn., May 1, 2006; 8(2): 277 - 281.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. Aure, G. Fayet, J. P. Leroy, E. Lacene, N. B. Romero, and A. Lombes
Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation
Brain, May 1, 2006; 129(5): 1249 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
R Andrews, T Ressiniotis, D M Turnbull, M Birch, S Keers, P F Chinnery, and P G Griffiths
The role of mitochondrial haplogroups in primary open angle glaucoma.
Br J Ophthalmol, April 1, 2006; 90(4): 488 - 490.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Karppa, R. Herva, A.-R. Moslemi, A. Oldfors, S. Kakko, and K. Majamaa
Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA
Brain, August 1, 2005; 128(8): 1861 - 1869.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. M. Lowik, F. A. Hol, E. J. Steenbergen, J. F. M. Wetzels, and L. P. W. J. van den Heuvel
Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis
Nephrol. Dial. Transplant., February 1, 2005; 20(2): 336 - 341.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Deschauer, P F Chinnery, A M Schaefer, D M Turnbull, R W Taylor, S Zierz, S Shanske, S DiMauro, K Majamaa, E Wilichowski, et al.
No association of the mitochondrial DNA A12308G polymorphism with increased risk of stroke in patients with the A3243G mutation
J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1204 - 1205.
[Full Text] [PDF]

Home page
 NeurologyHome page
P. Kaufmann, D. C. Shungu, M. C. Sano, S. Jhung, K. Engelstad, E. Mitsis, X. Mao, S. Shanske, M. Hirano, S. DiMauro, et al.
Cerebral lactic acidosis correlates with neurological impairment in MELAS
Neurology, April 27, 2004; 62(8): 1297 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
P F Chinnery and E A Schon
Mitochondria
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1188 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A M Remes, M Karppa, H Rusanen, K Majamaa, I E Hassinen, J S Moilanen, S Uimonen, M Sorri, P I Salmela, S-L Karvonen, et al.
Epidemiology of the mitochondrial DNA 8344A>G mutation for the myoclonus epilepsy and ragged red fibres (MERRF) syndrome
J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1158 - 1159.
[Full Text] [PDF]

Home page
 BrainHome page
T. Taivassalo, T. Dysgaard Jensen, N. Kennaway, S. DiMauro, J. Vissing, and R. G. Haller
The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients
Brain, February 1, 2003; 126(2): 413 - 423.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
J. Spiropoulos, D. M. Turnbull, and P. F. Chinnery
Can mitochondrial DNA mutations cause sperm dysfunction?
Mol. Hum. Reprod., August 1, 2002; 8(8): 719 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Deschauer, T. Muller, T. Wieser, W. Schulte-Mattler, M. Kornhuber, and S. Zierz
Hearing Impairment Is Common in Various Phenotypes of the Mitochondrial DNA A3243G Mutation
Arch Neurol, November 1, 2001; 58(11): 1885 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. Sternberg, E. Chatzoglou, P. Laforet, G. Fayet, C. Jardel, P. Blondy, M. Fardeau, S. Amselem, B. Eymard, and A. Lombes
Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders
Brain, May 1, 2001; 124(5): 984 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
, J. M. v. , R. , , , G. , H. , , J. , and A.
Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in Myoclonus Epilepsy and Ragged-Red Fibers (MERRF) syndrome by a multiplex Molecular Beacon based real-time fluorescence
Nucleic Acids Res., February 1, 2001; 29(3): e13 - e13.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A. CLARKE
The biology of mitochondrial disease
Arch. Dis. Child., May 1, 2000; 82(5): 339 - 340.
[Full Text]

Home page
 J. Med. Genet.Home page
P. F Chinnery, N. Howell, R. M Andrews, and D. M Turnbull
Clinical mitochondrial genetics
J. Med. Genet., June 1, 1999; 36(6): 425 - 436.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.